This trial will study whether combining two different types of therapy can help manage headaches related to mild traumatic brain injury.
- Traumatic Brain Injury
5 Primary · 6 Secondary · Reporting Duration: Change from baseline to 2-, 4-, 6-, 8-, 12-, 16-, and 20-weeks follow up visit
2 Treatment Groups
Active rTMS with telehealth headache management therapy
1 of 2
Sham rTMS with telehealth headache education control
1 of 2
240 Total Participants · 2 Treatment Groups
Primary Treatment: Active rTMS with telehealth headache management therapy · Has Placebo Group · N/A
Who is running the clinical trial?
Age 18 - 65 · All Participants · 6 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
Is there an upper age limit for enrolment in this trial?
"According to the eligibility requirements, those wishing to partake in this trial must be between 18 and 65 years old. Additionally, there are 252 studies available for minors and 1149 studies designed for seniors." - Anonymous Online Contributor
Who are the ideal participants for this clinical exploration?
"To be eligible for participation in this clinical trial, potential participants must experience headache symptoms and are required to fall within the 18-65 age range. In total, 240 people will take part of this research program." - Anonymous Online Contributor
Is there any opportunity for participants to join this clinical experiment?
"According to information on clinicaltrials.gov, this study is currently enlisting participants. The trial was originally posted on January 1st 2022 and the details were last altered on September 23rd 2022." - Anonymous Online Contributor
What is the current enrollment capacity for this medical study?
"Yes, the information available on clinicaltrials.gov confirms that this medical study is actively recruiting participants. The trial was first posted on January 1st 2022 and has been updated as of September 23rd 2022. This research requires 240 patients to be recruited from a single site." - Anonymous Online Contributor
What objectives are researchers hoping to attain with this trial?
"This study is designed to measure the improvement of Debilitating Headache Frequency from baseline over a period of 20 weeks. Secondary objectives include assessing patients' quality of life with the Headache Impact Test, Hamilton Rating Scale for Depression, and Short Form Health Survey-36. Each objective uses an individual scoring rubric that ranges from 0 to 100 or 6 to 13 depending on the metric. Higher scores indicate a larger degree of negative impact in regards to quality of life variables." - Anonymous Online Contributor